Abstract
Recent findings demonstrate that loss of ERAAP, an endoplasmic reticulum aminopeptidase involved in antigen processing, plays a key role in stimulating anti-tumor innate and adaptive immune responses. We show that MHC class I molecules produced in the absence of ERAAP retain their capability of presenting antigens to CD8(+) T cells, but not of inhibiting NK cells.
Lingua originale | English |
---|---|
pagine (da-a) | 81-82 |
Numero di pagine | 2 |
Rivista | OncoImmunology |
Volume | 1 |
DOI | |
Stato di pubblicazione | Pubblicato - 2012 |
Keywords
- N/A